Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates

Xenotransplantation

Volumn 6, Issue 3, 1999, Pages 194-200

  Chen, Raymond H ^a   Naficy, Sephre ^a   Logan, John S ^b   Diamond, Lisa E ^b   Adams, David H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Nextran   (United States)

Author keywords

Complements; Heart; Hyperacute rejection; Transgenic; Transplantation; Xenotransplantation

Indexed keywords

CD59 ANTIGEN; CYCLOSPORIN; DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN M; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRAMUSCULAR DRUG ADMINISTRATION; MOLECULAR CLONING; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; ANTIGENS, CD59; GENE TRANSFER TECHNIQUES; GRAFT SURVIVAL; HEART; HEART TRANSPLANTATION; HUMANS; PRIMATES; SWINE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032823020     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.1999.00017.x     Document Type: Article

References (21)

1. YE Y, NIEKRASZ M, KOSANKE S, et al. The pig as a potential organ donor for man. A study of potentially transferable disease from donor pig to recipient man. Transplantation 1994; 57: 694.
2. GALILI U, MACHER BA, BUEHLER J, SHOHET SB. Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1-3)-linked galactose residues. J Exp Med 1985; 162: 573.
3. PLATT JL, VERCELLOTTI GM, DALMASSO AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
4. AKAMI T, SAWADA R, MINATO N, et al. Cytoprotective effect of CD59 antigen on xenotransplantation immunity. Transplant Proc 1992; 24: 485.
5. DAVITZ MA. Decay-accelerating factor (DAF): a review of its function and structure. Acta Med Scand Suppl 1987; 715: 111.
6. MCCURRY KR, KOOYMAN DL, ALVARADO CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury [see comments]. Nature Med 1995; 1: 423.
7. DIAMOND LE, MCCURRY KR, MARTIN MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61: 1241.
8. BYRNE GW, MCCURRY KR, MARTIN MJ, MCCLELLAN SM, PLATT JL, LOGAN JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63 (1): 149.
9. LOGAN J, MARTIN M. Transgenic swine as a recombinant production for human hemoglobulin. Methods Enzymol 1994; 231: 435.
10. MICHLER RE, MCMANUS RP, SMITH CR, SADEGHI AN, ROSE EA. Technique for primate heterotopic cardiac xenotransplantation. J Med Primatol 1985; 14: 357.
11. ADAMS DH, WYNER LR, KARNOVSKY MJ. Experimental graft arteriosclerosis II, Immunocytochemical analysis of lesion development. Transplantation 1993; 56: 794.
12. AUCHINCLOSS H Jr Xenogeneic transplantation. Annu Rev Transplantation 1988; 46 (1): 1.
13. PLATT JL, FISCHEL RJ, MATAS AJ, REIF SA, BOLMAN RM, BACH FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52 (2): 214.
14. DALMASSO AP, PLATT JL, BACH FH. Reaction of complement with endothelial cells in a model of xenotransplantation. Clin Exp Immunol 1991; 86 (Suppl. 1): 31.
15. KATAYAMA A, OGAWA H, KADOMATSU K, et al. Studies of alpha-Gal dependent hyperacute xenotransplant rejection using double knockout embryonic stem cells. Transplant Proc 1997; 29: 2262.
16. WHITE DJ, OGLESBY T, LISZEWSKI MK, et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant Proc 1992; 24: 474.
17. ROLLINS SA, SIMS PJ. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 1990; 144: 3478.
18. EWULONU UK, RAVI L, MEDOF ME. Characterization of the decay-accelerating factor gene promoter region. Proc Natl Acad Sci USA 1991; 88: 4675.
19. PETRANKA J, ZHAO J, NORRIS J, et al. Structure-function relationships of the complement regulatory protein, CD59. Blood Cells Mol Dis 1996; 22 (3): 281.
20. SCHMOECKEL M, BHATTI FN, ZAIDI A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65: 1570.
21. LIN SS, PLATT JL. Immunologic barriers to xenotransplantation. J Heart Lung Transplant 1996; 15: 547.